These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3194931)

  • 1. Prevention of acquired defects in platelet function during blood processing.
    Washitani Y; Irita Y; Yamamoto K; Shiraki H; Kiyokawa H; Maeda Y; Yoshinari M
    Transfusion; 1988; 28(6):571-5. PubMed ID: 3194931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel technique for preparing improved buffy coat platelet concentrates.
    Mrowiec ZR; Oleksowicz L; Dutcher JP; De Leon-Fernandez M; Lalezari P; Puszkin EG
    Blood Cells Mol Dis; 1995; 21(1):25-33. PubMed ID: 7655858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet activation during preparation of platelet concentrates: a comparison of the platelet-rich plasma and the buffy coat methods.
    Fijnheer R; Pietersz RN; de Korte D; Gouwerok CW; Dekker WJ; Reesink HW; Roos D
    Transfusion; 1990 Sep; 30(7):634-8. PubMed ID: 2144922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Buffy coat platelets stored in apyrase, aprotinin, and ascorbic acid in a suspended bag: combined strategies for reducing platelet activation during storage.
    Mrowiec ZR; Oleksowicz L; Zuckerman D; De Leon-Fernandez M; Khorshidi M; Dutcher JP; Puszkin EG
    Transfusion; 1996 Jan; 36(1):5-10. PubMed ID: 8607153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet concentrates derived from buffy coat and apheresis: biochemical and functional differences.
    Böck M; Rahrig S; Kunz D; Lutze G; Heim MU
    Transfus Med; 2002 Oct; 12(5):317-24. PubMed ID: 12383338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of PGE1 for preparation of platelet concentrates.
    Menitove JE; Frenzke M; Aster RH
    Transfusion; 1986; 26(4):346-50. PubMed ID: 2941906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of a 12-hour, 22 degrees C holding period for buffy coats on the preparation of platelet concentrates stored in plasma.
    Boeri N; Saleun S; Pelissier E; Saleun JP; Aiach M; Rendu F
    Transfusion; 1994 Oct; 34(10):881-6. PubMed ID: 7940660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Blood fractionation based on the extraction of the buffy-coat layer. Analysis of our results].
    Algora M; Torres P; Rodríguez MA; de la Calle C; Biurrún M; Nieto S; Ruiz M; Alonso MV
    Sangre (Barc); 1995 Apr; 40(2):91-6. PubMed ID: 7784953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality assessment of buffy-coat-derived leucodepleted platelet concentrates in PAS-plasma, prepared by the OrbiSac or TACSI automated system.
    Plaza EM; Céspedes P; Fernández H; Sánchez-Guiu MI; Egea JM; Vicente V; Lozano ML; Rivera J
    Vox Sang; 2014 Jan; 106(1):38-44. PubMed ID: 23888911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro evaluation of buffy-coat-derived platelet concentrates stored in a synthetic medium.
    Fijnheer R; Veldman HA; van den Eertwegh AJ; Gouwerok CW; Homburg CH; Boomgaard MN; de Korte D; Roos D
    Vox Sang; 1991; 60(1):16-22. PubMed ID: 2053325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the Impact-R for monitoring the platelet storage lesion.
    Albanyan AM; Murphy MF; Harrison P
    Platelets; 2009 Feb; 20(1):1-6. PubMed ID: 19172514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro evaluation of platelet concentrates, prepared from pooled buffy coats, stored for 8 days after filtration.
    Boomgaard MN; Joustra-Dijkhuis AM; Gouwerok CW; Steneker I; Reesink HW; Loos JA; Pietersz RN; de Korte D
    Transfusion; 1994 Apr; 34(4):311-6. PubMed ID: 8178328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Quality of thrombocyte preparations from buffy coat or platelet-rich plasma].
    Bux J; Müller K; Misterek J; Mueller-Eckhardt C
    Beitr Infusionsther; 1990; 26():99-102. PubMed ID: 1703912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apyrase, ascorbic acid and aprotinin ameliorate the storage lesion in pelleted platelet preparations.
    Mrowiec ZR; Oleksowicz L; De Leon-Fernandez M; Lalezari P; Dutcher JP; Puszkin EG
    Biotech Histochem; 1997 Sep; 72(5):259-67. PubMed ID: 9408586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of prestorage white cell reduction on the function and viability of stored platelet concentrates.
    Dzik WH; Cusack WF; Sherburne B; Kickler T
    Transfusion; 1992 May; 32(4):334-9. PubMed ID: 1585438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overcoming the bottleneck of platelet lysate supply in large-scale clinical expansion of adipose-derived stem cells: A comparison of fresh versus three types of platelet lysates from outdated buffy coat-derived platelet concentrates.
    Glovinski PV; Herly M; Mathiasen AB; Svalgaard JD; Borup R; Talman MM; Elberg JJ; Kølle ST; Drzewiecki KT; Fischer-Nielsen A
    Cytotherapy; 2017 Feb; 19(2):222-234. PubMed ID: 27887865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective evaluation of platelets prepared by single and random methods during 5 days of storage: aspects related to quality and quantity.
    Kocazeybek B; Arabaci U; Akdur H; Sezgiç M; Erentürk S
    Transfus Apher Sci; 2002 Feb; 26(1):29-34. PubMed ID: 11931375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet quality after 15-day storage of platelet concentrates prepared from buffy coats and stored in a glucose-free crystalloid medium.
    Bertolini F; Rebulla P; Porretti L; Murphy S
    Transfusion; 1992 Jan; 32(1):9-16. PubMed ID: 1731448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The evolution of platelet procoagulant activity of remnant platelets in stored platelet concentrates prepared by the platelet-rich plasma method and the buffy coat method.
    Van der Planken MG; Vertessen F; Mortelmans E; Van Bockstaele D; Muylle L; Mertens G; Berneman ZN
    Ann Hematol; 1999 Jan; 78(1):1-7. PubMed ID: 10037261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementation of buffy coat platelet component production: comparison to platelet-rich plasma platelet production.
    Levin E; Culibrk B; Gyöngyössy-Issa MI; Weiss S; Scammell K; LeFresne W; Jenkins C; Devine DV
    Transfusion; 2008 Nov; 48(11):2331-7. PubMed ID: 18631169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.